11
Views
0
CrossRef citations to date
0
Altmetric
Review

The endocrine effects of acylated and des-acylated ghrelin

, , , &
Pages 31-40 | Published online: 27 Aug 2012

References

  • Bowers CY, Chamg J, Momany F, Folkers K. Effect of the Enkephalins and Enkephalin Analogs on the Release of Pituitary Hormones in Vitro. Amsterdam: Elsevier/North Holland Biomedical Press; 1977.
  • Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982;218(4572):585–587.
  • Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature. 1982;300(5889):276–278.
  • Patchett AA, Nargund RP, Tata JR, et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci U S A. 1995;92(15):7001–7005.
  • Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974–977.
  • Feighner SD, Tan CP, McKee KK, et al. Receptor for motilin identified in the human gastrointestinal system. Science. 1999;284(5423):2184–2188.
  • Howard AD, Wang R, Pong SS, et al. Identification of receptors for neuromedin U and its role in feeding. Nature. 2000;406(6791):70–74.
  • Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–660.
  • Civelli O, Nothacker HP, Saito Y, Wang Z, Lin SH, Reinscheid RK. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci. 2001;24(4):230–237.
  • Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85(2):495–522.
  • Matsumoto M, Hosoda H, Kitajima Y, et al. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun. 2001;287(1):142–146.
  • Nishi Y, Yoh J, Hiejima H, Kojima M. Structures and molecular forms of the ghrelin-family peptides. Peptides. 2011;32(11):2175–2182.
  • Yoh J, Nishi Y, Hosoda H, et al. Plasma levels of n-decanoyl ghrelin, another acyl- and active-form of ghrelin, in human subjects and the effect of glucose- or meal-ingestion on its dynamics. Regul Pept. 2011;167(1):140–148.
  • Kirchner H, Heppner KM, Tschop MH. The role of ghrelin in the control of energy balance. Handb Exp Pharmacol. 2012;209:161–184.
  • Seoane LM, Al-Massadi O, Barreiro F, Dieguez C, Casanueva FF. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J Endocrinol Invest. 2007;30(9):RC22-RC25.
  • Foster-Schubert KE, Overduin J, Prudom CE, et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab. 2008;93(5):1971–1979.
  • Marzullo P, Caumo A, Savia G, et al. Predictors of postabsorptive ghre- lin secretion after intake of different macronutrients. J Clin Endocrinol Metab. 2006;91(10):4124–4130.
  • Gomez G, Englander EW, Greeley GH Jr. Nutrient inhibition of ghrelin secretion in the fasted rat. Regul Pept. 2004;117(1):33–36.
  • Erdmann J, Lippl F, Schusdziarra V Differential effect of protein and fat on plasma ghrelin levels in man. Regul Pept. 2003;116(1–3):101–107.
  • Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–396.
  • Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279(3):909–913.
  • Benso A, St-Pierre DH, Prodam F, et al. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol. 2012;166(5):911–916.
  • St-Pierre DH, Karelis AD, Coderre L, et al. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. J Clin Endocrinol Metab. 2007;92(1):264–269.
  • Miegueu P, Pierre DS, Broglio F, Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem. 2011;112(2):704–714.
  • Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87(6):2988.
  • Kang K, Zmuda E, Sleeman MW. Physiological role of ghrelin as revealed by the ghrelin and GOAT knockout mice. Peptides. 2011;32(11):2236–2241.
  • Tarantini B, Ciuoli C, Checchi S, et al. Serum ghrelin levels in growth hormone-sufficient and growth hormone-deficient patients during growth hormone-releasing hormone plus arginine test. J Endocrinol Invest. 2009;32(4):335–337.
  • Lopez-Siguero JP, Lopez-Canti LF, Espino R, et al. Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-alpha and ghrelin levels in growth hormone- deficient children. J Endocrinol Invest. 2011;34(4):300–306.
  • Jung CH, Lee WY, Rhee EJ, et al. Serum ghrelin and leptin levels in adult growth hormone deficiency syndrome. Arch Med Res. 2006;37(5):612–618.
  • Pinsker JE, Ondrasik D, Chan D, et al. Total and acylated ghrelin levels in children with poor growth. Pediatr Res. 2011;69(6):517–521.
  • Anderson LL, Jeftinija S, Scanes CG, et al. Physiology of ghrelin and related peptides. Domest Anim Endocrinol. 2005;29(1):111–144.
  • Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2000;85(12):4908–4911.
  • Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908–913.
  • Olszewski PK, Grace MK, Billington CJ, Levine AS. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides. 2003;24(6):919–923.
  • Olszewski PK, Li D, Grace MK, Billington CJ, Kotz CM, Levine AS. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides. 2003;24(4):597–602.
  • Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001;50(11):2540–2547.
  • Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141(11):4325–4328.
  • Faulconbridge LF, Cummings DE, Kaplan JM, Grill HJ. Hyperphagic effects of brainstem ghrelin administration. Diabetes. 2003;52(9):2260–2265.
  • Egecioglu E, Jerlhag E, Salome N, et al. Ghrelin increases intake of rewarding food in rodents. Addict Biol. 2010;15(3):304–311.
  • Perello M, Sakata I, Birnbaum S, et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry. 2010;67(9):880–886.
  • Egecioglu E, Skibicka KP, Hansson C, et al. Hedonic and incentive signals for body weight control. Rev Endocr Metab Disord. 2011 ;12(3): 141–151.
  • Skibicka KP, Hansson C, Egecioglu E, Dickson SL. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict Biol. 2012;17(1):95–107.
  • Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008;7(5):400–409.
  • Wang L, Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y- synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett. 2002;325(1):47–51.
  • Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology. 2000;141(12):4797–4800.
  • Riediger T, Traebert M, Schmid HA, Scheel C, Lutz TA, Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett. 2003;341(2):151–155.
  • Jones RB, McKie S, Astbury N, et al. Functional neuroimaging demonstrates that ghrelin inhibits the central nervous system response to ingested lipid. Gut. Epub February 7, 2012.
  • Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007;12(1):6–16.
  • Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol. 2006;11(1):45–54.
  • Soderpalm B, Ericson M. Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points. Curr Top Behav Neurosci. Epub November 18, 2011.
  • Kaur S, Ryabinin AE. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res. 2010;34(9):1525–1534.
  • Kraus T, Schanze A, Groschl M, et al. Ghrelin levels are increased in alcoholism. Alcohol Clin Exp Res. 2005;29(12):2154–2157.
  • Jerlhag E, Egecioglu E, Dickson SL, Engel JA. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology. 2010;211(4):415–422.
  • Carlini VP, Gaydou RC, Schioth HB, de Barioglio SR. Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake. Regul Pept. 2007;140(1–2):65–73.
  • Carlini VP, Ghersi M, Schioth HB, de Barioglio SR. Ghrelin and memory: differential effects on acquisition and retrieval. Peptides. 2010;31(6):1190–1193.
  • Carlini VP, Monzon ME, Varas MM, et al. Ghrelin increases anxietylike behavior and memory retention in rats. Biochem Biophys Res Commun. 2002;299(5):739–743.
  • Andrews ZB, Erion D, Beiler R, et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. JNeurosci. 2009;29(45):14057–14065.
  • Jiang H, Li LJ, Wang J, Xie JX. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol. 2008;212(2):532–537.
  • Moon M, Kim HG, Hwang L, et al. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res. 2009;15(4):332–347.
  • Lim CT, Korbonits M. Paediatric endocrine aspects of ghrelin. Pediatr Endocrinol Rev. 2012;9(3):628–638.
  • Muller TD, Tschop MH, Jarick I, et al. Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. J Psychiatr Res. 2011;45(5):706–711.
  • Tannenbaum GS, Ramsay M, Martel C, et al. Elevated circulating acylated and total ghrelin concentrations along with reduced appetite scores in infants with failure to thrive. Pediatr Res. 2009;65(5):569–573.
  • Strasser F. Clinical application of ghrelin. Curr Pharm Des. Epub May 23, 2012.
  • Morillo-Bernal J, Fernandez-Santos JM, De Miguel M, et al. Ghrelin potentiates TSH-induced expression of the thyroid tissue-specific genes thyroglobulin, thyroperoxidase and sodium-iodine symporter, in rat PC-Cl3 Cells. Peptides. 2011;32(11):2333–2339.
  • Lim CT, Kola B, Grossman A, Korbonits M. The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J. 2011 ;58(8): 707–710.
  • Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm MetabRes. 2009;41(11):814–821.
  • Kluge M, Riedl S, Uhr M, et al. Ghrelin affects the hypothalamus- pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol. 2010;162(6):1059–1065.
  • Sawicka B, Bossowski A, Szalecki M, et al. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases. J Pediatr Endocrinol Metab. 2010;23(4):345–354.
  • El Gawad SS, El-Kenawy FM, Mousa AA, Omar AA. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism. Endocr Pract. 2012;18(3):376–381.
  • Kosowicz J, Baumann-Antczak A, Ruchala M, Gryczynska M, Gurgul E, Sowinski J. Thyroid hormones affect plasma ghrelin and obestatin levels. Horm Metab Res. 2011;43(2):121–125.
  • Tanda ML, Lombardi V, Genovesi M, et al. Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction. J Endocrinol Invest. 2009;32(1):74–78.
  • Altinova AE, Toruner FB, Akturk M, et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res. 2006;65(6):295–299.
  • Molica P, Nascif SO, Correa-Silva SR, de Sa LB, Vieira JG, Lengyel AM. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment. Pituitary. 2010;13(4):315–323.
  • Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab. 2003;88(2):853–857.
  • Sosic-Jurjevic B, Stevanovic D, Milosevic V, Sekulic M, Starcevic V Central ghrelin affects pituitary-thyroid axis: histomorpho- logical and hormonal study in rats. Neuroendocrinology. 2009;89(3):327–336.
  • Kamegai J, Tamura H, Ishii S, Sugihara H, Wakabayashi I. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrino. 2001;13(3):275–278.
  • Park YJ, Lee YJ, Kim SH, et al. Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells. Mol Cell Endocrinol. 2008;285(1–2):19–25.
  • Tai K, Visvanathan R, Hammond AJ, Wishart JM, Horowitz M, Chapman IM. Fasting ghrelin is related to skeletal muscle mass in healthy adults. Eur JNutr. 2009;48(3):176–183.
  • Vestergaard ET, Gormsen LC, Jessen N, et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes. 2008;57(12):3205–3210.
  • Bertoli S, Magni P, Krogh V et al. Is ghrelin a signal of decreased fat-free mass in elderly subjects? Eur J Endocrinol. 2006;155(2):321–330.
  • Vestergaard ET, Djurhuus CB, Gjedsted J, et al. Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab. 2008;93(2):438–444.
  • Vestergaard ET, Buhl M, Gjedsted J, et al. Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. J Clin Endocrinol Metab. 2011;96(2):468–477.
  • Barazzoni R, Zanetti M, Cattin MR, et al. Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats. Obesity. 2007;15(11):2614–2623.
  • Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondriallipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288(1):E228-E235.
  • Barazzoni R, Zanetti M, Semolic A, et al. High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. PloS One. 2011;6(10):e26224.
  • Pardo M, Roca-Rivada A, Al-Massadi O, Seoane LM, Camina JP, Casanueva FF. Peripheral leptin and ghrelin receptors are regulated in a tissue-specific manner in activity-based anorexia. Peptides. 2010;31(10):1912–1919.
  • Pierno S, De Luca A, Desaphy JF, et al. Growth hormone secre- tagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor. Br J Pharmacol. 2003;139(3):575–584.
  • Ghanbari-Niaki A, Abednazari H, Tayebi SM, Hossaini-Kakhak A, Kraemer RR. Treadmill training enhances rat agouti-related protein in plasma and reduces ghrelin levels in plasma and soleus muscle. Metab Clin Exp. 2009;58(12):1747–1752.
  • Barazzoni R, Zhu X, Deboer M, et al. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int. 2010;77(1):23–28.
  • Balasubramaniam A, Joshi R, Su C, et al. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. Am J Physiol Regul Integr Comp Physiol. 2009;296(4):R893-R901.
  • Sheriff S, Kadeer N, Joshi R, Friend LA, James JH, BalasubramaniamA. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol Cell Endocrinol. 2012;351(2):286–295.
  • Montoya-Flores D, Mora O, Tamariz E, et al. Ghrelin stimulates myogenic differentiation in a mouse muscle satellite cell line and in primary cultures of bovine myoblasts. JAnim Physiol Anim Nutr (Berl). Epub July 21, 2011.
  • Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell. 2007;18(3):986–994.
  • Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87(1):240–244.
  • Zwirska-Korczala K, Konturek SJ, Sodowski M, et al. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol. 2007;58 Suppl 1:13–35.
  • Rodriguez A, Gomez-Ambrosi J, Catalan V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond). 2009;33(5):541–552.
  • Miegueu P, St Pierre D, Broglio F, Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem. 2011;112(2):704–714.
  • Kos K, Harte AL, O’Hare PJ, Kumar S, McTernan PG. Ghrelin and the differential regulation of des-acyl (DSG) and octanoyl ghrelin (OTG) in human adipose tissue (AT). Clin Endocrinol. 2009;70(3):383–389.
  • Lin L, Saha PK, Ma X, et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell. 2011;10(6):996–1010.
  • Mano-Otagiri A, Iwasaki-Sekino A, Nemoto T, et al. Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. RegulPept. 2010;160(1–3):81–90.
  • Sangiao-Alvarellos S, Vazquez MJ, Varela L, et al. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology. 2009;150(10):4562–4574.
  • Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116(7):1983–1993.
  • Schreiber JE, Singh NK, Shermak MA. The effect of liposuction and diet on ghrelin, adiponectin, and leptin levels in obese Zucker rats. PlastReconstr Surg. 2006;117(6):1829–1835.
  • Soares VM, Garcia-Souza EP, Lacerda-Miranda G, Moura AS. Early life overfeeding decreases acylated ghrelin circulating levels and upregulates GHSR1a signaling pathway in white adipose tissue of obese young mice. Regul Pept. 2012;174(1–3):6–11.
  • Choi K, Roh SG, Hong YH, et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology. 2003;144(3):754–759.
  • Satou M, Nakamura Y, Ando H, Sugimoto H. Understanding the functional significance of ghrelin processing and degradation. Peptides. 2011;32(11):2183–2190.
  • Pettinelli P, Obregon AM, Videla LA. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. Nutr Hosp. 2011;26(3):441–450.
  • Pisto P, Ukkola O, Santaniemi M, Kesaniemi YA. Plasma adiponectin – an independent indicator of liver fat accumulation. Metab Clin Exp. 2011;60(11):1515–1520.
  • Estep M, Abawi M, Jarrar M, et al. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obe Surg. 2011;21(11):1750–1757.
  • Pavlidis C, Panoutsopoulos GI, Tiniakos D, Koutsounas S, Vlachogiannakos J, Zouboulis-Vafiadis I. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis. World J Gastroenterol. 2011;17(46):5097–5104.
  • Sajjad A, Mottershead M, Syn WK, Jones R, Smith S, Nwokolo CU. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005;22(4):291–299.
  • Marchesini G, Pagotto U, Bugianesi E, et al. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab. 2003;88(12):5674–5679.
  • Heijboer AC, van den Hoek AM, Parlevliet ET, et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia. 2006;49(4):732–738.
  • Gauna C, Delhanty PJ, Hofland LJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab. 2005;90(2):1055–1060.
  • Rigault C, Le Borgne F, Georges B, Demarquoy J. Ghrelin reduces hepatic mitochondrial fatty acid beta oxidation. J Endocrinol Invest. 2007;30(4):RC4–RC8.
  • Muccioli G, Lorenzi T, Lorenzi M, et al. Beyond the metabolic role of ghrelin: a new player in the regulation of reproductive function. Peptides. 2011;32(12):2514–2521.
  • Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340(1):44–58.
  • Miegueu P, Cianflone K, Richard D, St-Pierre DH. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage. Am J Physiol Endocrinol Metab. 2011;301(5):E758–E766.